Expert Perspectives 2026

Publikum sitzt in einem Konferenzraum und hört einer Präsentation zu; links oben ist das Cellex‑Logo zu sehen.

Cell and Gene Therapy at a Turning Point

Welcome to our video library presenting the recorded sessions from our scientific symposium, “Cell and Gene Therapy at a Turning Point” held in November 2026 in Cologne. Bringing together leading experts, the event showcased pioneering research, strategic perspectives, and practical insights. This curated collection offers a comprehensive and forward-looking view of the opportunities and challenges shaping the field of cell and gene therapy.

Dr. Jens Altrichter

Artcline

Rethinking Sepsis: The Potential of Allogeneic Immune-Cell Therapy  Opportunities and Challenges

Dr. Matthias Domogalla

Cellex Cell Professionals

Turning Quality into Performance: Using GMP Compliance to Optimize Cell Therapy Manufacturing

Ali Mohamed, Ph.D.

Immatics Biotechnologies

Translating PRAME Targeting into TCR-T Cell Product Development
and Manufacturing

Prof. Dr. med. Martin Wermke

Dresden University of Technology

Addressing Difficult to Target Antigens in Solid Tumors and
Hematologic Malignancies in the Clinic

Dr. Suvi Annala

Cellex Cell Professionals

One Partner, Every Scale: An Integrated CDMO Perspective on
Commercialization

Dr. Hyatt Balke-Want

University Hospital Cologne

From Code to Cure:
Genome Engineering in T Cells

Prof. Dr. med. Elke Jäger

North-West Hospital Frankfurt

Harnessing Tumor-Specific T Cells and Peptide Vaccines for Cancer
Immunotherapy

Ping Shek

STBIO

China’s Biotech Industry
in the Global Context